RE: Suspension1 May 2024 08:40
I have just under 1% of the company float, so dare not dream about a buy out. I know the directors would not consider any petty sums for a takeover, especially with their current cash position, ability to attract European Union backed non dilutive grants, 2 patents pending, 4 core programmes in development, overarching protection from other awarded patents and billion dollar deals being agreed for early stage pharma companies.
I’m going to try remain hopeful but realistic that it’s just a due diligence exercise and good conduct on behalf of the company, or I might make myself sick with shock.